Dashboard
Manage Tickers

CABACabaletta Bio, Inc.

Nasdaq www.cabalettabio.com


$ 10.68 $ -1.90 (-15.13 %)    

Friday, 14-Jun-2024 15:59:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.30 $ 2.47 (0.52 %)
DIA $ 386.46 $ -0.42 (-0.11 %)
SPY $ 542.65 $ 0.33 (0.06 %)
TLT $ 94.67 $ 0.79 (0.84 %)
GLD $ 215.76 $ 2.76 (1.3 %)
$ 10.66
$ 13.57
$ 0.00 x 0
$ 0.00 x 0
$ 10.05 - $ 13.74
$ 9.52 - $ 26.35
4,729,625
na
514.63M
$ 1.54
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 03-21-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 03-16-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 05-12-2022 03-31-2022 10-Q
10 03-17-2022 12-31-2021 10-K
11 11-01-2021 09-30-2021 10-Q
12 08-05-2021 06-30-2021 10-Q
13 05-03-2021 03-31-2021 10-Q
14 03-16-2021 12-31-2020 10-K
15 11-10-2020 09-30-2020 10-Q
16 08-06-2020 06-30-2020 10-Q
17 05-12-2020 03-31-2020 10-Q
18 03-30-2020 12-31-2019 10-K
19 12-05-2019 09-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

why-ammo-shares-are-trading-lower-by-over-19-here-are-other-stocks-moving-in-fridays-mid-day-session
Why AMMO Shares Are Trading Lower By Over ...
06/14/2024 18:13:08

hc-wainwright--co-reiterates-buy-on-cabaletta-bio-maintains-30-price-target
HC Wainwright & Co. Reiterates Buy on Caba...
06/14/2024 15:09:29

HC Wainwright & Co. analyst Douglas Tsao reiterates Cabaletta Bio (NASDAQ:CABA) with a Buy and maintains $30 price target.

cabaletta-bio-announces-initial-clinical-data-from-phase-12-reset-myositis-and-reset-sle-trials-of-caba-201
Cabaletta Bio Announces Initial Clinical D...
06/14/2024 07:25:17

– No CRS, ICANS, infections or serious adverse events observed in either of the first two patients through data cut-off of May ...

cabaletta-bio-13g-filing-shows-jennison-associates-llc-reports-111-passive-stake-in-the-co-as-of-may-31-2024
Cabaletta Bio 13G Filing Shows Jennison As...
06/06/2024 17:08:53

- SEC Filing

hc-wainwright--co-reiterates-buy-on-cabaletta-bio-maintains-30-price-target
HC Wainwright & Co. Reiterates Buy on Caba...
05/24/2024 10:31:15

HC Wainwright & Co. analyst Douglas Tsao reiterates Cabaletta Bio (NASDAQ:CABA) with a Buy and maintains $30 price target.

hc-wainwright--co-reiterates-buy-on-cabaletta-bio-maintains-30-price-target
HC Wainwright & Co. Reiterates Buy on Caba...
05/16/2024 11:54:44

HC Wainwright & Co. analyst Douglas Tsao reiterates Cabaletta Bio (NASDAQ:CABA) with a Buy and maintains $30 price target.

why-bolt-biotherapeutics-shares-are-trading-lower-by-around-34-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why Bolt Biotherapeutics Shares Are Tradin...
05/15/2024 17:38:38

nextracker-posts-upbeat-earnings-joins-mondaycom-nu-holdings-and-other-big-stocks-moving-higher-on-wednesday
NEXTracker Posts Upbeat Earnings, Joins mo...
05/15/2024 14:21:59

cabaletta-bio-expects-that-its-cash-cash-equivalents-and-short-term-investments-of-2238m-as-of-march-31-2024-will-enable-it-to-fund-its-operating-plan-into-the-first-half-of-2026
Cabaletta Bio Expects That Its Cash, Cash ...
05/15/2024 11:12:43

cabaletta-bio-q1-2024-gaap-eps-051-misses-047-estimate
Cabaletta Bio Q1 2024 GAAP EPS $(0.51) Mis...
05/15/2024 11:11:42

cantor-fitzgerald-reiterates-overweight-on-cabaletta-bio-maintains-50-price-target
Cantor Fitzgerald Reiterates Overweight on...
04/05/2024 13:19:03

Cantor Fitzgerald analyst Joshua Schimmer reiterates Cabaletta Bio (NASDAQ:CABA) with a Overweight and maintains $50 price t...

citigroup-maintains-buy-on-cabaletta-bio-raises-price-target-to-30
Citigroup Maintains Buy on Cabaletta Bio, ...
04/04/2024 15:47:06

Citigroup analyst Samantha Semenkow maintains Cabaletta Bio (NASDAQ:CABA) with a Buy and raises the price target from $26 to...

cabaletta-bio-issued-idnct06328777-for-phase-12-open-label-study-to-evaluate-the-safety-and-efficacy-of-caba-201-a-cd19-car-t-cell-therapy-in-subjects-with-systemic-sclerosis-posted-to-clinical-trials-website-on-2024-03-25-study-is-not-yet-recruiting
Cabaletta Bio Issued ID#NCT06328777 For Ph...
03/25/2024 14:25:25

https://clinicaltrials.gov/study/NCT06328777   Inclusion Criteria:

cantor-fitzgerald-reiterates-overweight-on-cabaletta-bio-maintains-50-price-target
Cantor Fitzgerald Reiterates Overweight on...
03/22/2024 17:54:33

Cantor Fitzgerald analyst Joshua Schimmer reiterates Cabaletta Bio (NASDAQ:CABA) with a Overweight and maintains $50 price t...

wells-fargo-maintains-overweight-on-cabaletta-bio-raises-price-target-to-35
Wells Fargo Maintains Overweight on Cabale...
03/22/2024 17:40:24

Wells Fargo analyst Derek Archila maintains Cabaletta Bio (NASDAQ:CABA) with a Overweight and raises the price target from $...

hc-wainwright--co-maintains-buy-on-cabaletta-bio-raises-price-target-to-30
HC Wainwright & Co. Maintains Buy on Cabal...
03/22/2024 14:55:45

HC Wainwright & Co. analyst Douglas Tsao maintains Cabaletta Bio (NASDAQ:CABA) with a Buy and raises the price target fr...

recap-cabaletta-bio-q4-earnings
Recap: Cabaletta Bio Q4 Earnings
03/21/2024 13:10:06

cabaletta-bio-inc-files-for-mixed-shelf-offering-size-not-disclosed
Cabaletta Bio Inc Files For Mixed Shelf Of...
03/21/2024 12:05:33

- SEC Filing

cabaletta-bio-q4-eps-046-misses-039-estimate-cabaletta-had-cash-cash-equivalents-and-short-term-investments-of-2412m-expected-to-fund-its-operating-plan-into-the-first-half-of-2026
Cabaletta Bio Q4 EPS $(0.46) Misses $(0.39...
03/21/2024 11:22:50

Cabaletta Bio (NASDAQ:CABA) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of $(0.3...

fda-granted-orphan-drug-designation-to-cabaletta-bios-caba-201-for-treatment-of-systemic-sclerosis
FDA Granted Orphan Drug Designation To Cab...
03/20/2024 11:03:04

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)